Cypress Capital Management (Wyoming)’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-59,490	Closed	-$1.45M	–	353
2017 Q4	$1.45M	Sell	59,490 -7,475	-11%	-$144K	1.64%	13
2017 Q3	$1.24M	Buy	66,965 +3,425	+5%	+$59.3K	1.46%	15
2017 Q2	$1.05M	Buy	+63,540	New	+$884K	1.21%	18

Cypress Capital Management (Wyoming)'s ENTL Position: Q1 2018 in Review

Cypress Capital Management (Wyoming) sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 59,490 shares — an estimated $1.45M sold.

Cypress Capital Management (Wyoming) first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $1.45M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Cypress Capital Management (Wyoming) reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Cypress Capital Management (Wyoming) sold 59,490 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.45M.
Cypress Capital Management (Wyoming) first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Cypress Capital Management (Wyoming)'s Entellus Medical, Inc. Common Stock position peaked at $1.45M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2018, filed 3 May 2018.